SHIVA GUPTA to ErbB Receptors
This is a "connection" page, showing publications SHIVA GUPTA has written about ErbB Receptors.
Connection Strength
0.176
-
Bystander Effects, Pharmacokinetics, and Linker-Payload Stability of EGFR-Targeting Antibody-Drug Conjugates Losatuxizumab Vedotin and Depatux-M in Glioblastoma Models. Clin Cancer Res. 2024 Aug 01; 30(15):3287-3297.
Score: 0.128
-
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma. Neuro Oncol. 2021 12 01; 23(12):2042-2053.
Score: 0.027
-
Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma. Nat Commun. 2018 11 21; 9(1):4904.
Score: 0.022